Stock Market 20 February 2026 - 21 February 2026

Academy Sports Shares Could Move 8% Next Week as Wall Street Eyes Key Figure

Academy Sports Shares Could Move 8% Next Week as Wall Street Eyes Key Figure

Academy Sports and Outdoors shares fell 2.3% to $51.38 ahead of fiscal Q1 results due June 9. Options markets imply an 8.2% move on earnings, with analysts expecting EPS of 94 cents and revenue of $1.44 billion. The company raised its Q1 sales outlook to up 6%-7% and plans to update 2026 guidance. Academy opened two stores in Q1 and expects 20-25 new locations in 2026.
June 3, 2026
Saudi stocks head into Founding Day break after sharp Tadawul drop; oil and banks in focus

Saudi stocks head into Founding Day break after sharp Tadawul drop; oil and banks in focus

Saudi Arabia’s Tadawul All Share Index closed down 1.87% at 10,947.25, with banks falling 2.34% and decliners outnumbering gainers 253 to 14. Brent crude rose 1.9% to $71.66 a barrel amid U.S.-Iran tensions. Almarai’s board proposed a share buyback for an employee plan, while Saudi Fisheries posted a narrowed 2025 net loss of 25.35 million riyals. The next trading session is set for Feb. 23 after the Founding Day holiday.
February 21, 2026
NSE unlisted share price today: ₹2,084 as bourse flags new gold futures and tighter F&O margins

NSE unlisted share price today: ₹2,084 as bourse flags new gold futures and tighter F&O margins

NSE unlisted shares traded near ₹2,084 in private deals on Feb. 21, Planify data showed, as the exchange prepares for a public listing. NSE will launch 10-gram gold futures from March 16 after SEBI approval and impose an extra 15% exposure margin on 18 F&O stocks from the March 2026 series. The new margin rules take effect Feb. 25.
February 21, 2026
Oracle stock price slides 5% after OpenAI’s $600 billion compute plan surfaces; ORCL traders eye Nvidia next

Oracle stock price slides 5% after OpenAI’s $600 billion compute plan surfaces; ORCL traders eye Nvidia next

Oracle shares dropped 5.4% to $148.08 in after-hours trading Friday, underperforming a U.S. market lifted by the Supreme Court’s removal of Trump-era tariffs. The decline followed headlines on OpenAI’s soaring infrastructure costs and fundraising, with investors eyeing Nvidia’s Feb. 25 results and Oracle’s 2026 funding plan for further signals.
February 21, 2026
Microsoft (MSFT) stock slips despite director’s $2 million buy as AI spending stays under the microscope

Microsoft (MSFT) stock slips despite director’s $2 million buy as AI spending stays under the microscope

Microsoft shares fell 0.3% to $397.23 Friday, trailing a broader Wall Street rally as investors weighed the company’s AI spending and governance signals. Director John W. Stanton bought 5,000 shares for about $2 million, according to an SEC filing. Microsoft pledged $50 billion in AI investment for developing countries and said it will match all electricity use with renewable energy. The company denied its tech is used for mass surveillance by U.S. immigration authorities.
February 20, 2026
ASX 200 today: Australian shares end week near records as banks cushion Rio Tinto hit

ASX 200 today: Australian shares end week near records as banks cushion Rio Tinto hit

Australia’s S&P/ASX 200 slipped 4.8 points to 9,081.4 on Friday but gained 1.8% for the week after hitting a record high. Bank stocks rose on strong earnings, offsetting losses in miners after Rio Tinto’s annual results missed estimates. Investors are watching for upcoming results from Woodside, Woolworths, Coles, and Qantas. The Australian dollar held near $0.7056.
February 20, 2026
Lam Research stock jumps on BofA top-pick call; Nvidia earnings are the next catalyst

Lam Research stock jumps on BofA top-pick call; Nvidia earnings are the next catalyst

Lam Research shares climbed 2.4% to $243.19 Friday after BofA Securities reiterated a Buy rating and forecast $135 billion in 2026 wafer fabrication equipment spending. Nvidia, Applied Materials, and KLA also rose ahead of Nvidia’s earnings report next week, which analysts expect to show a 71% profit jump. Investors remain cautious about high valuations in AI-linked stocks.
February 20, 2026
Nebius Group N.V. (NBIS) stock slides below $100 as options buzz meets capex nerves

Nebius Group N.V. (NBIS) stock slides below $100 as options buzz meets capex nerves

Nebius Group (NBIS) shares fell 8% to $99.12 Friday, reversing earlier gains after hitting $108.30 in morning trade. The drop followed a two-day rally sparked by bullish analyst coverage and heavy options activity. Investors are watching funding and execution risks tied to Nebius’ $16–20 billion 2026 capital plan. Trading volume topped 12.8 million shares, with implied volatility near 94%.
February 20, 2026
Bank of America stock today: BAC ticks up as $25 billion private-credit push lands on a nervous market

Bank of America stock today: BAC ticks up as $25 billion private-credit push lands on a nervous market

Bank of America shares rose 0.4% to $52.96 Friday after Reuters reported the bank is setting aside $25 billion for private-credit deals. Investors are monitoring liquidity strains in private credit and awaiting the next Federal Reserve meeting and earnings reports. Blue Owl shares fell 4% after it sold $1.4 billion in loans and restricted redemptions.
February 20, 2026
FTSE 100 today: UK shares end at record close on upbeat data, tariff ruling

FTSE 100 today: UK shares end at record close on upbeat data, tariff ruling

The FTSE 100 closed up 59.85 points at 10,686.89 on Friday, topping its previous record, after strong UK retail sales and a U.S. Supreme Court ruling that ended Trump-era tariffs. January retail sales volumes jumped 1.8% from December, the biggest monthly rise since May 2024. The pound hovered near a one-month low, while UK business activity edged higher but private-sector jobs fell for a 17th month.
February 20, 2026
India stock market today: Nifty, Sensex rebound despite oil jitters; Feb 27 GDP reset in focus

India stock market today: Nifty, Sensex rebound despite oil jitters; Feb 27 GDP reset in focus

Indian shares closed higher Friday, with the Nifty 50 up 0.46% and the Sensex gaining 0.38%, after late profit-taking trimmed earlier gains. The rupee fell to 90.9825 per U.S. dollar, its steepest weekly drop in over a month. Novartis India surged nearly 20% after Novartis agreed to sell its majority stake for $159 million. India VIX rose to 14.36, near an eight-month high, as volatility persisted.
February 20, 2026
Dow Jones slips as tariff-ruling rally fades; inflation data keeps Wall Street cautious

Dow Jones slips as tariff-ruling rally fades; inflation data keeps Wall Street cautious

The Dow fell 141 points by midday Friday, erasing early gains after the U.S. Supreme Court struck down Trump’s global tariffs. The court ruled 6-3 that Trump exceeded his authority, but left refund questions unresolved. Slower GDP growth and higher core inflation weighed on rate-cut hopes. Treasury yields stayed firm amid uncertainty over potential tariff refunds.
February 20, 2026
Eli Lilly stock slips in New York: why Barclays’ $1,350 call isn’t lifting LLY yet

Eli Lilly stock slips in New York: why Barclays’ $1,350 call isn’t lifting LLY yet

Eli Lilly shares dropped 1.6% to $1,006.78 Friday morning, underperforming the S&P 500 ETF’s 0.6% gain. Barclays began coverage with an Overweight rating and a $1,350 target, citing strong prospects for GLP-1 weight-loss drugs. Novo Nordisk’s U.S. shares fell 1.9%. Lilly reported new data showing long-term remission with Omvoh in Crohn’s disease and announced a $100 million deal with CSL for clazakizumab rights.
February 20, 2026
Akamai (AKAM) stock drops as memory costs bite guidance; Wall Street watches capex, pricing

Akamai (AKAM) stock drops as memory costs bite guidance; Wall Street watches capex, pricing

Akamai shares dropped 9.3% to $99.38 Friday after the company warned of higher memory costs and issued a weaker-than-expected first-quarter profit outlook. CEO Tom Leighton said memory prices have “probably doubled” due to AI infrastructure demand. Fourth-quarter revenue rose 7% to $1.095 billion, with security revenue up 11%. Akamai forecast 2026 capital spending at 23% to 26% of revenue.
February 20, 2026
JPMorgan Chase stock price today: JPM edges up as ECB fine, Trump case and insider sale hit the tape

JPMorgan Chase stock price today: JPM edges up as ECB fine, Trump case and insider sale hit the tape

JPMorgan Chase shares rose 0.2% to $308.60 Friday as the S&P 500 and Nasdaq climbed after the U.S. Supreme Court struck down Trump’s global tariffs. The European Central Bank fined JPMorgan’s European arm €12.18 million for misreporting capital requirements. JPMorgan and CEO Jamie Dimon challenged Trump’s $5 billion lawsuit over closed accounts. Co-CEO Troy Rohrbaugh sold 50,000 shares on Feb. 19.
February 20, 2026
Oracle (ORCL) stock slides as OpenAI’s $100 billion fundraise and Nvidia earnings loom

Oracle (ORCL) stock slides as OpenAI’s $100 billion fundraise and Nvidia earnings loom

Oracle shares dropped 2.7% to $152.25 Friday morning, trailing a broader market rally after the U.S. Supreme Court struck down Trump-era tariffs. Nvidia is nearing a $30 billion investment in OpenAI as part of a funding round topping $100 billion, a source said. Investors are watching for Nvidia’s results next week for signals on AI spending and data-center expansion.
February 20, 2026
1 84 85 86 87 88 127

Stock Market Today

  • Biome Australia to Onshore Activated Probiotics Production for Margin Boost
    June 3, 2026, 2:30 AM EDT. Biome Australia (ASX: BIO) has inked a manufacturing deal with Specialty Probiotics Australia to produce its Activated Probiotics range domestically. This strategic move aims to streamline the supply chain by reducing reliance on international freight, enabling smaller batch sizes, and improving stock turnover. Biome expects onshore production to lift gross margins from 61% to over 65% within 18 months, starting with the first commercial batch in September. The company will maintain European manufacturing for regional markets to ensure supply diversity. CEO Blair Vega Norfolk called the shift a key step in Biome's long-term Vision 27 ITALS plan, enhancing control over manufacturing inputs, intellectual property, and product quality. CFO Lauren Dwyer highlighted margin gains without capital expenditure, underscoring Biome's disciplined financial management.